FI914405A0 - Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat. - Google Patents

Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat.

Info

Publication number
FI914405A0
FI914405A0 FI914405A FI914405A FI914405A0 FI 914405 A0 FI914405 A0 FI 914405A0 FI 914405 A FI914405 A FI 914405A FI 914405 A FI914405 A FI 914405A FI 914405 A0 FI914405 A0 FI 914405A0
Authority
FI
Finland
Prior art keywords
isoprenoidphospholipas
inhibitorer
preparat
dessa innehaollande
och dessa
Prior art date
Application number
FI914405A
Other languages
English (en)
Other versions
FI914405A (fi
FI104168B1 (fi
FI104168B (fi
Inventor
F Ivy Carroll
Anita Lewin
Kenneth Tramposch
Stephen A Steiner
Original Assignee
Bristol Myers Squipp Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squipp Company filed Critical Bristol Myers Squipp Company
Publication of FI914405A0 publication Critical patent/FI914405A0/fi
Publication of FI914405A publication Critical patent/FI914405A/fi
Application granted granted Critical
Publication of FI104168B1 publication Critical patent/FI104168B1/fi
Publication of FI104168B publication Critical patent/FI104168B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FI914405A 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi FI104168B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/586,159 US5141959A (en) 1990-09-21 1990-09-21 Isoprenoid phospholipase a2 inhibitors and preparations comprising same
US58615990 1990-09-21

Publications (4)

Publication Number Publication Date
FI914405A0 true FI914405A0 (fi) 1991-09-19
FI914405A FI914405A (fi) 1992-03-22
FI104168B1 FI104168B1 (fi) 1999-11-30
FI104168B FI104168B (fi) 1999-11-30

Family

ID=24344545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914405A FI104168B (fi) 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi

Country Status (18)

Country Link
US (1) US5141959A (fi)
EP (1) EP0476682B1 (fi)
JP (1) JP2943089B2 (fi)
AT (1) ATE117979T1 (fi)
AU (1) AU637756B2 (fi)
CA (1) CA2051766A1 (fi)
DE (1) DE69107153T2 (fi)
DK (1) DK0476682T3 (fi)
ES (1) ES2067822T3 (fi)
FI (1) FI104168B (fi)
GR (1) GR3014944T3 (fi)
IE (1) IE66745B1 (fi)
IL (1) IL99536A (fi)
MX (1) MX9101163A (fi)
NZ (1) NZ239844A (fi)
OA (1) OA09514A (fi)
PT (1) PT99014B (fi)
ZA (1) ZA917531B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189737B2 (en) 1991-08-09 2007-03-13 Research Triangle Institute Cocaine receptor binding ligands
US5688781A (en) 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
US6267945B1 (en) * 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP1511477A4 (en) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
WO2003101177A2 (en) * 2002-06-04 2003-12-11 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
AU2003248794B2 (en) * 2002-06-27 2007-10-04 Harkness Pharmaceuticals, Inc. Therapeutic methods for reducing fat deposition and treating associated conditions
AU2003248793A1 (en) * 2002-06-27 2004-01-19 Sequenom, Inc Diagnosing predisposition to fat deposition and associated condition
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors
US7872023B2 (en) * 2005-02-17 2011-01-18 Research Triangle Institute Kappa opioid receptor ligands
US7399762B2 (en) * 2005-04-25 2008-07-15 Research Triangle Institute Opioid receptor agonist compounds and their use in treatment of pain
US7476679B2 (en) * 2005-07-26 2009-01-13 Research Triangle Institute Octahydroisoquinoline compounds as opioid receptor modulators
US20090170841A1 (en) * 2007-04-20 2009-07-02 Acucela Inc. Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
US8048895B2 (en) * 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
JP6173693B2 (ja) 2010-02-24 2017-08-02 リサーチ・トライアングル・インスティチュート アリールピペラジンオピオイド受容体アンタゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
US4456618A (en) * 1982-10-15 1984-06-26 Sri International Naphthenic and heterocyclic retinoic acid analogues
US4568757A (en) * 1984-01-30 1986-02-04 Research Triangle Institute Configurationally locked retinoids

Also Published As

Publication number Publication date
PT99014B (pt) 1999-02-26
PT99014A (pt) 1992-08-31
FI914405A (fi) 1992-03-22
NZ239844A (en) 1993-04-28
EP0476682A1 (en) 1992-03-25
FI104168B1 (fi) 1999-11-30
IE913318A1 (en) 1992-02-25
FI104168B (fi) 1999-11-30
MX9101163A (es) 1992-05-04
OA09514A (en) 1992-11-15
AU637756B2 (en) 1993-06-03
EP0476682B1 (en) 1995-02-01
AU8462691A (en) 1992-03-26
ES2067822T3 (es) 1995-04-01
DE69107153D1 (de) 1995-03-16
DK0476682T3 (da) 1995-04-03
CA2051766A1 (en) 1992-03-22
ZA917531B (en) 1992-07-29
IE66745B1 (en) 1996-02-07
IL99536A0 (en) 1992-08-18
JPH04270261A (ja) 1992-09-25
DE69107153T2 (de) 1995-05-24
US5141959A (en) 1992-08-25
GR3014944T3 (en) 1995-05-31
IL99536A (en) 1995-10-31
JP2943089B2 (ja) 1999-08-30
ATE117979T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
FI914405A0 (fi) Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat.
DE69221794T2 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
DE69705480T2 (de) Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
DE69808099T2 (de) Substituierte 6-alkylphenanthridine
DE3869692D1 (de) Zellproliferationsinhibitor.
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
BR9103665A (pt) Composicao inseticida e processo para a producao de um composto
PT81556B (pt) Processo para a preparacao de agentes anti-fungicos de triazole
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
DE69302087D1 (de) Trazodone alkyl derivate mit zns wirkung
DE69101960T2 (de) Pradimicinderivate.
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
DE69527854T2 (de) Derivate substituierter amidinonaphthylester
JPS54122727A (en) Fungicidal, antiseptic, anti-termitic agent
FI840005A (fi) Triorganotenn-acetylsalicylat och dessa innehaollande biocida aemnen.
GB2021106A (en) Isopropylbenzene derivatives
DK0802900T3 (da) Antiarytmiske (S)-enantiomerer af methansulfonamider